首页 > 最新文献

Biomedical Technology最新文献

英文 中文
HFF-Net: A hybrid convolutional neural network for diabetic retinopathy screening and grading HFF-Net:用于糖尿病视网膜病变筛查和分级的混合卷积神经网络
Pub Date : 2024-10-07 DOI: 10.1016/j.bmt.2024.09.004
Muhammad Hassaan Ashraf , Hamed Alghamdi
Diabetic Retinopathy (DR) is a leading cause of vision loss among diabetic patients, necessitating effective screening and grading for timely intervention. Regular screening significantly increases the workload of ophthalmologists, and accurate grading into stages—mild, moderate, severe, and proliferative—is crucial for monitoring disease progression. While Computer-Aided Diagnosis (CAD) systems can alleviate this burden, existing Convolutional Neural Network (CNN)-based frameworks use fixed-size kernels in a linear feed-forward manner. This approach can lead to information loss in the initial stages due to limited feature utilization across adjacent layers. To address this limitation, we propose a Hierarchical Features Fusion Convolutional Neural Network (HFF-Net) within a Diabetic Retinopathy Screening and Grading (DRSG) framework. The framework includes preprocessing to extract regions of interest from fundus images (FIs), enhancement using Contrast Limited Adaptive Histogram Equalization (CLAHE), and data augmentation for class balancing and overfitting mitigation. HFF-Net extracts multiscale features that fused at multiple levels within the network, utilizing the swish activation function for improved learning stability. We evaluated HFF-Net against several state-of-the-art CNN classifiers within the DRSG framework. Experimental results demonstrate that HFF-Net achieves a grading accuracy of 73.77 ​%, surpassing the second-best model by 3.51 percentage points (a relative improvement of approximately 5 ​%), and attains a screening accuracy of 98.70 ​% using only 1.18 million parameters. These findings highlight HFF-Net's potential as an efficient and effective tool in CAD systems for DR screening and grading.
©2017 Elsevier Inc. All rights reserved.
糖尿病视网膜病变(DR)是导致糖尿病患者视力丧失的主要原因,因此必须进行有效筛查和分级,以便及时干预。定期筛查大大增加了眼科医生的工作量,而准确分级--轻度、中度、重度和增殖期--对监测疾病进展至关重要。虽然计算机辅助诊断(CAD)系统可以减轻这一负担,但现有的基于卷积神经网络(CNN)的框架以线性前馈方式使用固定大小的核。由于相邻层之间的特征利用率有限,这种方法可能会导致初始阶段的信息丢失。为了解决这一局限性,我们在糖尿病视网膜病变筛查和分级(DRSG)框架内提出了分层特征融合卷积神经网络(HFF-Net)。该框架包括从眼底图像(FIs)中提取感兴趣区域的预处理、使用对比度受限自适应直方图均衡化(CLAHE)进行增强,以及用于类平衡和减轻过拟合的数据增强。HFF-Net 可提取多尺度特征,并在网络内多层次融合,利用swish 激活函数提高学习稳定性。我们在 DRSG 框架内对 HFF-Net 与几种最先进的 CNN 分类器进行了评估。实验结果表明,HFF-Net 的分级准确率达到了 73.77%,比排名第二的模型高出 3.51 个百分点(相对提高约 5%),并且仅使用 118 万个参数就达到了 98.70% 的筛选准确率。这些发现凸显了 HFF-Net 作为 CAD 系统中用于 DR 筛选和分级的高效工具的潜力。保留所有权利。
{"title":"HFF-Net: A hybrid convolutional neural network for diabetic retinopathy screening and grading","authors":"Muhammad Hassaan Ashraf ,&nbsp;Hamed Alghamdi","doi":"10.1016/j.bmt.2024.09.004","DOIUrl":"10.1016/j.bmt.2024.09.004","url":null,"abstract":"<div><div>Diabetic Retinopathy (DR) is a leading cause of vision loss among diabetic patients, necessitating effective screening and grading for timely intervention. Regular screening significantly increases the workload of ophthalmologists, and accurate grading into stages—mild, moderate, severe, and proliferative—is crucial for monitoring disease progression. While Computer-Aided Diagnosis (CAD) systems can alleviate this burden, existing Convolutional Neural Network (CNN)-based frameworks use fixed-size kernels in a linear feed-forward manner. This approach can lead to information loss in the initial stages due to limited feature utilization across adjacent layers. To address this limitation, we propose a Hierarchical Features Fusion Convolutional Neural Network (HFF-Net) within a Diabetic Retinopathy Screening and Grading (DRSG) framework. The framework includes preprocessing to extract regions of interest from fundus images (FIs), enhancement using Contrast Limited Adaptive Histogram Equalization (CLAHE), and data augmentation for class balancing and overfitting mitigation. HFF-Net extracts multiscale features that fused at multiple levels within the network, utilizing the swish activation function for improved learning stability. We evaluated HFF-Net against several state-of-the-art CNN classifiers within the DRSG framework. Experimental results demonstrate that HFF-Net achieves a grading accuracy of 73.77 ​%, surpassing the second-best model by 3.51 percentage points (a relative improvement of approximately 5 ​%), and attains a screening accuracy of 98.70 ​% using only 1.18 million parameters. These findings highlight HFF-Net's potential as an efficient and effective tool in CAD systems for DR screening and grading.</div><div>©2017 Elsevier Inc. All rights reserved.</div></div>","PeriodicalId":100180,"journal":{"name":"Biomedical Technology","volume":"8 ","pages":"Pages 50-64"},"PeriodicalIF":0.0,"publicationDate":"2024-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142421086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biomaterials that passively and actively target macrophages promote the regeneration of injured tissues 被动和主动靶向巨噬细胞的生物材料可促进受伤组织的再生
Pub Date : 2024-10-01 DOI: 10.1016/j.bmt.2024.09.005
Pengzhen Zhuang, Wu Yang, Yu Chen, Yu Zhang, Capucine Leboucher, Jessica M. Rosenholm, Hongbo Zhang
Modulation of the immune system has gained significant attention in regenerative medicine. Although most tissues possess intrinsic self-repair capabilities, large-sized defects and complex pathological conditions may still lead to tissue microenvironment imbalance and repair failure. Researchers have applied macrophage-mediated immunotherapeutic strategies to various injured tissue repairs by modulating inflammatory responses, intercellular communication, and multitissue synergies to restore immune microenvironmental homeostasis and promote tissue regeneration. Ongoing advancements in materials science have highlighted the precise immunomodulatory role of biomaterials, with passive targeting strategies based on the material's physicochemical properties and active targeting strategies based on specific molecular modifications becoming increasingly important in research. This review focuses on the mechanisms of action of actively and passively targeted biomaterials to modulate macrophages, which improve the tissue regenerative microenvironment through four basic strategies: (i) modulation of the inflammatory response to remove damaged cells, cellular debris, and pathogens; (ii) remodeling of the extracellular matrix; (iii) reconstruction of vascular tissues; and (iv) macrophage-stem cell crosstalk. This review covers the major mechanisms of macrophage action in the regeneration of injured tissues, while exploring the multiple methods by which advanced biomaterials target macrophages and highlighting their applications in the regeneration of a wide range of tissue injuries. We further discuss the future directions and current limitations in the development of biomaterials for macrophage modulation, aiming to advance biomaterials targeting macrophages, realize the full potential of immunotherapy, and achieve precision medicine.
免疫系统的调节在再生医学中备受关注。虽然大多数组织具有内在的自我修复能力,但大面积缺损和复杂的病理条件仍可能导致组织微环境失衡和修复失败。研究人员已将巨噬细胞介导的免疫治疗策略应用于各种损伤组织的修复,通过调节炎症反应、细胞间通讯和多组织协同作用来恢复免疫微环境的平衡,促进组织再生。材料科学的不断进步凸显了生物材料的精确免疫调节作用,基于材料理化特性的被动靶向策略和基于特定分子修饰的主动靶向策略在研究中变得越来越重要。本综述重点探讨主动和被动靶向生物材料调节巨噬细胞的作用机制,巨噬细胞通过四种基本策略改善组织再生微环境:(i) 调节炎症反应以清除受损细胞、细胞碎片和病原体;(ii) 重塑细胞外基质;(iii) 重建血管组织;(iv) 巨噬细胞-干细胞串联。这篇综述涵盖了巨噬细胞在损伤组织再生中的主要作用机制,同时探讨了先进生物材料靶向巨噬细胞的多种方法,并重点介绍了它们在各种组织损伤再生中的应用。我们还进一步讨论了巨噬细胞调控生物材料的未来发展方向和目前的局限性,旨在推进以巨噬细胞为靶标的生物材料的发展,充分发挥免疫疗法的潜力,实现精准医疗。
{"title":"Biomaterials that passively and actively target macrophages promote the regeneration of injured tissues","authors":"Pengzhen Zhuang,&nbsp;Wu Yang,&nbsp;Yu Chen,&nbsp;Yu Zhang,&nbsp;Capucine Leboucher,&nbsp;Jessica M. Rosenholm,&nbsp;Hongbo Zhang","doi":"10.1016/j.bmt.2024.09.005","DOIUrl":"10.1016/j.bmt.2024.09.005","url":null,"abstract":"<div><div>Modulation of the immune system has gained significant attention in regenerative medicine. Although most tissues possess intrinsic self-repair capabilities, large-sized defects and complex pathological conditions may still lead to tissue microenvironment imbalance and repair failure. Researchers have applied macrophage-mediated immunotherapeutic strategies to various injured tissue repairs by modulating inflammatory responses, intercellular communication, and multitissue synergies to restore immune microenvironmental homeostasis and promote tissue regeneration. Ongoing advancements in materials science have highlighted the precise immunomodulatory role of biomaterials, with passive targeting strategies based on the material's physicochemical properties and active targeting strategies based on specific molecular modifications becoming increasingly important in research. This review focuses on the mechanisms of action of actively and passively targeted biomaterials to modulate macrophages, which improve the tissue regenerative microenvironment through four basic strategies: (i) modulation of the inflammatory response to remove damaged cells, cellular debris, and pathogens; (ii) remodeling of the extracellular matrix; (iii) reconstruction of vascular tissues; and (iv) macrophage-stem cell crosstalk. This review covers the major mechanisms of macrophage action in the regeneration of injured tissues, while exploring the multiple methods by which advanced biomaterials target macrophages and highlighting their applications in the regeneration of a wide range of tissue injuries. We further discuss the future directions and current limitations in the development of biomaterials for macrophage modulation, aiming to advance biomaterials targeting macrophages, realize the full potential of immunotherapy, and achieve precision medicine.</div></div>","PeriodicalId":100180,"journal":{"name":"Biomedical Technology","volume":"8 ","pages":"Pages 17-49"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142421136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative exploration of deep convolutional neural networks using real-time endoscopy images 利用实时内窥镜图像对深度卷积神经网络进行比较探索
Pub Date : 2024-09-20 DOI: 10.1016/j.bmt.2024.09.003
Subhashree Mohapatra , Pukhraj Singh Jeji , Girish Kumar Pati , Manohar Mishra , Tripti Swarnkar

Until now various deep convolutional neural networks are designed and trained for the purpose of classifying different medical conditions related to the domain of gastroenterology. Most of the study carried out have considered publicly available datasets to train the classification networks. Nevertheless, the main motive for carrying out different works in the field gastroenterology is to administer the developed models in healthcare centers in real-world set-ups. For doing so, it is important to check the generalizing ability of the designed systems by regulating them so as to classify endoscopy images captured in a specific hospital. In this regard, the foremost work completed is the collection of the endoscopy data from the hospital and then correctly annotating the images taking the help of a senior endoscopist with experience of more than 5 years. Once the data annotation is completed, the images are segregated into the class of normal and abnormal endoscopy images. Four different models are designed in the current work based on deep learning models, transfer learning models and ensemble approaches, and trained to classify the hospital endoscopy data as normal or abnormal. The models are then tested and evaluated based on various performance measures. It is observed from the comparative analysis that the transfer learning-based ensemble model has the best generalizing ability and gives the best specificity of 100 ​%. It is believed that deep learning-based models can assist endoscopists in add-on to human prediction efficiency.

迄今为止,人们设计并训练了各种深度卷积神经网络,用于对与肠胃病学领域相关的不同病症进行分类。已开展的大多数研究都考虑使用公开可用的数据集来训练分类网络。然而,在胃肠病学领域开展不同研究的主要动机是在医疗保健中心的实际设置中应用所开发的模型。为此,重要的是通过调节所设计的系统来检查其通用能力,以便对特定医院拍摄的内窥镜图像进行分类。在这方面,首先要完成的工作是从医院收集内窥镜检查数据,然后在一位有 5 年以上经验的资深内窥镜医师的帮助下正确标注图像。数据标注完成后,图像将被分为正常和异常内窥镜图像。目前的工作基于深度学习模型、迁移学习模型和集合方法设计了四种不同的模型,并通过训练将医院内窥镜检查数据分为正常和异常。然后根据各种性能指标对模型进行测试和评估。从比较分析中可以看出,基于迁移学习的集合模型具有最好的泛化能力,特异性最好,达到 100%。相信基于深度学习的模型可以帮助内镜医师提高人类预测效率。
{"title":"Comparative exploration of deep convolutional neural networks using real-time endoscopy images","authors":"Subhashree Mohapatra ,&nbsp;Pukhraj Singh Jeji ,&nbsp;Girish Kumar Pati ,&nbsp;Manohar Mishra ,&nbsp;Tripti Swarnkar","doi":"10.1016/j.bmt.2024.09.003","DOIUrl":"10.1016/j.bmt.2024.09.003","url":null,"abstract":"<div><p>Until now various deep convolutional neural networks are designed and trained for the purpose of classifying different medical conditions related to the domain of gastroenterology. Most of the study carried out have considered publicly available datasets to train the classification networks. Nevertheless, the main motive for carrying out different works in the field gastroenterology is to administer the developed models in healthcare centers in real-world set-ups. For doing so, it is important to check the generalizing ability of the designed systems by regulating them so as to classify endoscopy images captured in a specific hospital. In this regard, the foremost work completed is the collection of the endoscopy data from the hospital and then correctly annotating the images taking the help of a senior endoscopist with experience of more than 5 years. Once the data annotation is completed, the images are segregated into the class of normal and abnormal endoscopy images. Four different models are designed in the current work based on deep learning models, transfer learning models and ensemble approaches, and trained to classify the hospital endoscopy data as normal or abnormal. The models are then tested and evaluated based on various performance measures. It is observed from the comparative analysis that the transfer learning-based ensemble model has the best generalizing ability and gives the best specificity of 100 ​%. It is believed that deep learning-based models can assist endoscopists in add-on to human prediction efficiency.</p></div>","PeriodicalId":100180,"journal":{"name":"Biomedical Technology","volume":"8 ","pages":"Pages 1-16"},"PeriodicalIF":0.0,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949723X2400028X/pdfft?md5=e0845db8abb3c72b5f176a9ea7db3750&pid=1-s2.0-S2949723X2400028X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142270561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of orthotic insole on symptomatic flexible flatfoot in school-age children: Meta-analysis and 1-year follow-up study 矫形鞋垫对学龄儿童症状性灵活扁平足的影响:元分析和一年随访研究
Pub Date : 2024-08-29 DOI: 10.1016/j.bmt.2024.08.001
Shuncai Hu, Qing Lin, Lifeng Qiu, Yang Liu, Siyan Guan, Zhizhi Luo, Yang Wang, Xiaofan Wang

Purpose

This study aimed to investigate the efficacy of orthopedic insoles, specifically three-dimensional (3D)-printed orthopedic insoles, for treatment of symptomatic flexible flatfoot in school-age children.

Methods

A systematic review of PubMed and China National Knowledge Infrastructure (CNKI) from database inception to March 2024 was conducted to determine additional studies. This single-center study included 38 participants, including 20 who chose ordinary orthopedic insoles and 18 who chose 3D printed orthopedic insoles, presented from January 2021 to December 2022. Pain symptom relief was compared between the two groups after 1 year of follow-up.

Results

A systematic review identified an additional six publications, involving 206 samples, and meta-analysis indicated that the force-bearing area, arch index, and heel valgus angle after treatment were 0.74 (95 ​% confidence interval [CI]: 0.65–1.01), 0.20 (95 ​% CI: 0.03–1.35), and 0.10 (95 ​% CI: 0.03–0.28) of those before treatment, respectively. The 1-year follow-up study revealed that because of its good comfort, 3D printed orthopedic insole can significantly improve the wearing time of both male (P ​< ​0.001) and overweight participants (P ​< ​0.001) and significantly reduce the pain score (P ​= ​0.032).

Conclusions

Orthotic insoles are effective in helping the recovery of flexible flatfoot. Among them, the 3D-printed orthopedic insoles have a better effect on relieving pain symptoms and have a great development potential.

目的 本研究旨在探讨矫形鞋垫(特别是三维(3D)打印矫形鞋垫)治疗学龄儿童症状性柔性扁平足的疗效。方法 对PubMed和中国国家知识基础设施(CNKI)从数据库开始到2024年3月的数据进行系统性回顾,以确定更多的研究。这项单中心研究纳入了 38 名参与者,其中 20 人选择了普通矫形鞋垫,18 人选择了 3D 打印矫形鞋垫,研究时间为 2021 年 1 月至 2022 年 12 月。结果系统性回顾发现了另外六篇出版物,涉及206个样本,荟萃分析表明治疗后的受力面积、足弓指数和足跟外翻角度分别为治疗前的0.74(95%置信区间[CI]:0.65-1.01)、0.20(95% CI:0.03-1.35)和0.10(95% CI:0.03-0.28)。1年的随访研究显示,3D打印矫形鞋垫因其良好的舒适性,可显著改善男性(P < 0.001)和超重参与者(P < 0.001)的穿着时间,并显著降低疼痛评分(P = 0.032)。结论矫形鞋垫能有效帮助灵活型扁平足的恢复,其中三维打印矫形鞋垫对缓解疼痛症状有较好的效果,具有很大的发展潜力。
{"title":"Effect of orthotic insole on symptomatic flexible flatfoot in school-age children: Meta-analysis and 1-year follow-up study","authors":"Shuncai Hu,&nbsp;Qing Lin,&nbsp;Lifeng Qiu,&nbsp;Yang Liu,&nbsp;Siyan Guan,&nbsp;Zhizhi Luo,&nbsp;Yang Wang,&nbsp;Xiaofan Wang","doi":"10.1016/j.bmt.2024.08.001","DOIUrl":"10.1016/j.bmt.2024.08.001","url":null,"abstract":"<div><h3>Purpose</h3><p>This study aimed to investigate the efficacy of orthopedic insoles, specifically three-dimensional (3D)-printed orthopedic insoles, for treatment of symptomatic flexible flatfoot in school-age children.</p></div><div><h3>Methods</h3><p>A systematic review of PubMed and China National Knowledge Infrastructure (CNKI) from database inception to March 2024 was conducted to determine additional studies. This single-center study included 38 participants, including 20 who chose ordinary orthopedic insoles and 18 who chose 3D printed orthopedic insoles, presented from January 2021 to December 2022. Pain symptom relief was compared between the two groups after 1 year of follow-up.</p></div><div><h3>Results</h3><p>A systematic review identified an additional six publications, involving 206 samples, and meta-analysis indicated that the force-bearing area, arch index, and heel valgus angle after treatment were 0.74 (95 ​% confidence interval [CI]: 0.65–1.01), 0.20 (95 ​% CI: 0.03–1.35), and 0.10 (95 ​% CI: 0.03–0.28) of those before treatment, respectively. The 1-year follow-up study revealed that because of its good comfort, 3D printed orthopedic insole can significantly improve the wearing time of both male (<em>P</em> ​&lt; ​0.001) and overweight participants (<em>P</em> ​&lt; ​0.001) and significantly reduce the pain score (<em>P</em> ​= ​0.032).</p></div><div><h3>Conclusions</h3><p>Orthotic insoles are effective in helping the recovery of flexible flatfoot. Among them, the 3D-printed orthopedic insoles have a better effect on relieving pain symptoms and have a great development potential.</p></div>","PeriodicalId":100180,"journal":{"name":"Biomedical Technology","volume":"7 ","pages":"Pages 63-70"},"PeriodicalIF":0.0,"publicationDate":"2024-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949723X24000163/pdfft?md5=b0f8149d222ae2bd36d56643a01112ba&pid=1-s2.0-S2949723X24000163-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142089408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emerging strategies for the treatment of endometriosis 治疗子宫内膜异位症的新策略
Pub Date : 2024-08-29 DOI: 10.1016/j.bmt.2024.08.002
Qiong Chen , Jing Wang , Xiaoya Ding , Qingfei Zhang , Ping Duan

Endometriosis is an estrogen-dependent disorder of the reproductive tract, affecting approximately 10 ​% of women. The symptoms of this condition are vague and not correlated with the disease's stage. These associated symptoms significantly impact women's overall well-being. The etiology of endometriosis remains inadequately understood, with coelomic metaplasia, lymphatic and vascular dissemination being regarded as additional hypotheses in addition to the retrograde menstruation theory. Endometriosis is primarily treated with drug therapy and surgical intervention, but the recurrence rate of symptoms after five years remains approximately 50 ​%. Therefore, the advancement of more effective and safe therapies for the treatment of endometriosis is of paramount importance. In this review, we introduce the utilization of photodynamic therapy, hyperthermia, gene therapy, immunotherapy, stem cell therapy, nanotechnology, and micron technology in the management of endometriosis. The objective is to provide novel research perspectives for therapeutic approaches and facilitate future clinical translation to enhance patient outcomes.

子宫内膜异位症是一种依赖雌激素的生殖道疾病,约有 10% 的妇女会患病。这种疾病的症状比较模糊,而且与疾病的阶段无关。这些相关症状严重影响了妇女的整体健康。人们对子宫内膜异位症的病因仍不十分清楚,除月经逆行理论外,还有一些其他的假说,如子宫内膜移行症、淋巴和血管播散等。子宫内膜异位症主要采用药物治疗和手术干预,但五年后症状复发率仍高达约 50%。因此,开发更有效、更安全的子宫内膜异位症治疗方法至关重要。在这篇综述中,我们将介绍光动力疗法、热疗、基因疗法、免疫疗法、干细胞疗法、纳米技术和微米技术在子宫内膜异位症治疗中的应用。目的是为治疗方法提供新的研究视角,并促进未来的临床转化,以提高患者的治疗效果。
{"title":"Emerging strategies for the treatment of endometriosis","authors":"Qiong Chen ,&nbsp;Jing Wang ,&nbsp;Xiaoya Ding ,&nbsp;Qingfei Zhang ,&nbsp;Ping Duan","doi":"10.1016/j.bmt.2024.08.002","DOIUrl":"10.1016/j.bmt.2024.08.002","url":null,"abstract":"<div><p>Endometriosis is an estrogen-dependent disorder of the reproductive tract, affecting approximately 10 ​% of women. The symptoms of this condition are vague and not correlated with the disease's stage. These associated symptoms significantly impact women's overall well-being. The etiology of endometriosis remains inadequately understood, with coelomic metaplasia, lymphatic and vascular dissemination being regarded as additional hypotheses in addition to the retrograde menstruation theory. Endometriosis is primarily treated with drug therapy and surgical intervention, but the recurrence rate of symptoms after five years remains approximately 50 ​%. Therefore, the advancement of more effective and safe therapies for the treatment of endometriosis is of paramount importance. In this review, we introduce the utilization of photodynamic therapy, hyperthermia, gene therapy, immunotherapy, stem cell therapy, nanotechnology, and micron technology in the management of endometriosis. The objective is to provide novel research perspectives for therapeutic approaches and facilitate future clinical translation to enhance patient outcomes.</p></div>","PeriodicalId":100180,"journal":{"name":"Biomedical Technology","volume":"7 ","pages":"Pages 46-62"},"PeriodicalIF":0.0,"publicationDate":"2024-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949723X24000175/pdfft?md5=62b25ff0bb6b24e2e05534564539033a&pid=1-s2.0-S2949723X24000175-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142089407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nano-enhanced nature medicine for ischemic stroke: Opportunities and challenges 治疗缺血性中风的纳米增强自然医学:机遇与挑战
Pub Date : 2024-07-16 DOI: 10.1016/j.bmt.2024.07.001
Jihao Yang , Lingyi Guo , Jun Liao , Huaqiang Yi

Ischemic stroke (IS), a major cause of death and disability globally, requires innovative therapeutic approaches due to its complex pathology. Nature medicine (NM) offers promising treatments through its bioactive compounds, which target the multifaceted nature of stroke-induced damage. However, the clinical application of NM is limited by challenges in bioavailability and specificity. This review article presents an advanced perspective on integrating nanotechnology with NM to create potent nanodelivery systems for ischemic stroke treatment. We highlight the pathological underpinnings of ischemic stroke, including oxidative stress, inflammation, and apoptosis, and discuss how NM compounds offer targeted mitigation strategies. By incorporating nanodelivery platforms, such as liposomes and nanoparticles, these NM -based treatments can achieve enhanced targeting, solubility, and controlled release, significantly improving therapeutic outcomes while reducing side effects. Despite promising developments, the translation of nano-enhanced NM into clinical practice faces obstacles, including manufacturing scalability, regulatory approval, and safety evaluations. This review emphasizes the potential of combining nanotechnology with NM to advance ischemic stroke therapy, calling for integrated research efforts to overcome existing barriers and fully realize the clinical benefits of this innovative approach.

缺血性中风(IS)是全球死亡和残疾的主要原因,由于其病理复杂,需要创新的治疗方法。自然医学(NM)通过其生物活性化合物针对中风引起的多方面损伤提供了有前景的治疗方法。然而,由于生物利用度和特异性方面的挑战,NM 的临床应用受到了限制。这篇综述文章以先进的视角介绍了如何将纳米技术与 NM 相结合,以创建用于缺血性中风治疗的强效纳米给药系统。我们强调了缺血性中风的病理基础,包括氧化应激、炎症和细胞凋亡,并讨论了 NM 化合物如何提供有针对性的缓解策略。通过结合脂质体和纳米颗粒等纳米给药平台,这些基于 NM 的疗法可以实现更强的靶向性、溶解性和控释性,从而在减少副作用的同时显著提高治疗效果。尽管发展前景广阔,但将纳米增强型 NM 转化为临床实践仍面临重重障碍,包括生产的可扩展性、监管审批和安全性评估。本综述强调了纳米技术与 NM 的结合在推进缺血性中风治疗方面的潜力,呼吁开展综合研究,以克服现有障碍,充分实现这种创新方法的临床益处。
{"title":"Nano-enhanced nature medicine for ischemic stroke: Opportunities and challenges","authors":"Jihao Yang ,&nbsp;Lingyi Guo ,&nbsp;Jun Liao ,&nbsp;Huaqiang Yi","doi":"10.1016/j.bmt.2024.07.001","DOIUrl":"10.1016/j.bmt.2024.07.001","url":null,"abstract":"<div><p>Ischemic stroke (IS), a major cause of death and disability globally, requires innovative therapeutic approaches due to its complex pathology. Nature medicine (NM) offers promising treatments through its bioactive compounds, which target the multifaceted nature of stroke-induced damage. However, the clinical application of NM is limited by challenges in bioavailability and specificity. This review article presents an advanced perspective on integrating nanotechnology with NM to create potent nanodelivery systems for ischemic stroke treatment. We highlight the pathological underpinnings of ischemic stroke, including oxidative stress, inflammation, and apoptosis, and discuss how NM compounds offer targeted mitigation strategies. By incorporating nanodelivery platforms, such as liposomes and nanoparticles, these NM -based treatments can achieve enhanced targeting, solubility, and controlled release, significantly improving therapeutic outcomes while reducing side effects. Despite promising developments, the translation of nano-enhanced NM into clinical practice faces obstacles, including manufacturing scalability, regulatory approval, and safety evaluations. This review emphasizes the potential of combining nanotechnology with NM to advance ischemic stroke therapy, calling for integrated research efforts to overcome existing barriers and fully realize the clinical benefits of this innovative approach.</p></div>","PeriodicalId":100180,"journal":{"name":"Biomedical Technology","volume":"7 ","pages":"Pages 32-45"},"PeriodicalIF":0.0,"publicationDate":"2024-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949723X24000151/pdfft?md5=7ca6bcfb5188479a44a70cc5ccf9f911&pid=1-s2.0-S2949723X24000151-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141623405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The therapeutic efficacy of post-symptom 3,4-diaminopyridine treatment in cosmetic injection-induced botulism using a novel animal model 利用新型动物模型研究症状后 3,4-二氨基吡啶治疗美容注射引起的肉毒中毒的疗效
Pub Date : 2024-07-02 DOI: 10.1016/j.bmt.2024.06.003
Ping He , Rongshuai Yan , Jie Liu , Pan You , Jianghe Zhang , Jinqing Li , Yiming Zhang

In recent years, the incidence of cosmetic injection-induced botulism has remarkably increased due to the frequent usage of botulinum neurotoxin type A (BoNT/A). To mimic and investigate this new clinical type of botulism, we established a novel animal model and evaluated the therapeutic potential of a new drug. Firstly, we injected BoNT/A into the gastrocnemius of rats to induce partial paralysis of the remaining limbs. Then, the intoxicated rats were treated with 3,4-diaminopyridine (3,4-DAP) at different stages of the disease and the forelimbs grasping strength (FGS) was evaluated. We showed that, at the sublethal dose, the FGS began to decrease at 6.00 ​± ​1.86 ​h after injection in rats, from 2.28 ​± ​0.19 ​N to 1.51 ​± ​0.18 ​N, while the FGS declined appeared earlier (4.29 ​± ​0.42 ​h) at the lethal dose, from 2.30 ​± ​0.20 ​N to 1.20 ​± ​0.16 ​N. Treatment with 3,4-DAP respectively at the time of the symptoms onset or 7 days after injection both can temporarily reverse the symptoms of muscle paralysis, indicating that 3,4-DAP may be an effective approach to relieve botulism. Overall, this study provides an available rat model and a promising therapeutic strategy for cosmetic injection-induced botulism.

近年来,由于A型肉毒杆菌神经毒素(BoNT/A)的频繁使用,美容注射诱发肉毒中毒的发病率显著上升。为了模拟和研究这种新型肉毒中毒临床类型,我们建立了一种新型动物模型,并评估了一种新药的治疗潜力。首先,我们向大鼠的腓肠肌注射 BoNT/A,诱导其余肢体部分瘫痪。然后,在疾病的不同阶段用 3,4-二氨基吡啶(3,4-DAP)治疗中毒大鼠,并评估其前肢抓握力量(FGS)。我们发现,在亚致死剂量下,大鼠的 FGS 在注射后 6.00 ± 1.86 h 开始下降,从 2.28 ± 0.19 N 降至 1.51 ± 0.18 N,而在致死剂量下,FGS 下降的时间更早(4.29 ± 0.42 h),从 2.30 ± 0.20 N 降至 1.20 ± 0.16 N。在症状出现时或注射后7天分别使用3,4-DAP治疗均可暂时逆转肌肉麻痹症状,表明3,4-DAP可能是缓解肉毒中毒的有效方法。总之,这项研究为化妆品注射引起的肉毒中毒提供了一个可用的大鼠模型和一种有前景的治疗策略。
{"title":"The therapeutic efficacy of post-symptom 3,4-diaminopyridine treatment in cosmetic injection-induced botulism using a novel animal model","authors":"Ping He ,&nbsp;Rongshuai Yan ,&nbsp;Jie Liu ,&nbsp;Pan You ,&nbsp;Jianghe Zhang ,&nbsp;Jinqing Li ,&nbsp;Yiming Zhang","doi":"10.1016/j.bmt.2024.06.003","DOIUrl":"https://doi.org/10.1016/j.bmt.2024.06.003","url":null,"abstract":"<div><p>In recent years, the incidence of cosmetic injection-induced botulism has remarkably increased due to the frequent usage of botulinum neurotoxin type A (BoNT/A). To mimic and investigate this new clinical type of botulism, we established a novel animal model and evaluated the therapeutic potential of a new drug. Firstly, we injected BoNT/A into the gastrocnemius of rats to induce partial paralysis of the remaining limbs. Then, the intoxicated rats were treated with 3,4-diaminopyridine (3,4-DAP) at different stages of the disease and the forelimbs grasping strength (FGS) was evaluated. We showed that, at the sublethal dose, the FGS began to decrease at 6.00 ​± ​1.86 ​h after injection in rats, from 2.28 ​± ​0.19 ​N to 1.51 ​± ​0.18 ​N, while the FGS declined appeared earlier (4.29 ​± ​0.42 ​h) at the lethal dose, from 2.30 ​± ​0.20 ​N to 1.20 ​± ​0.16 ​N. Treatment with 3,4-DAP respectively at the time of the symptoms onset or 7 days after injection both can temporarily reverse the symptoms of muscle paralysis, indicating that 3,4-DAP may be an effective approach to relieve botulism. Overall, this study provides an available rat model and a promising therapeutic strategy for cosmetic injection-induced botulism.</p></div>","PeriodicalId":100180,"journal":{"name":"Biomedical Technology","volume":"7 ","pages":"Pages 25-31"},"PeriodicalIF":0.0,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949723X2400014X/pdfft?md5=33b378da876cfcc1ef62239719647f35&pid=1-s2.0-S2949723X2400014X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141540325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Proteomic insights into myopia development: Differential protein expression and the role of calcium signaling in form deprivation myopia in Guinea pigs 蛋白质组学对近视发展的启示:蛋白质表达差异和钙信号在豚鼠形觉剥夺性近视中的作用
Pub Date : 2024-06-11 DOI: 10.1016/j.bmt.2024.06.001
Rongbin Liang , Tao Li , Wenqing Shi , Hui Gao , Bei Ai , Bing Li , Xiaodong Zhou

This study aims to explore the changes in the vitreous proteomics of form deprivation myopia (FDM) in guinea pigs, in order to reveal the molecular mechanisms involved in the onset and development of myopia. The myopia model in guinea pigs was successfully established by covering one eye of the guinea pigs with a latex bead sac for 4 weeks. This study used 4D data-independent acquisition proteomics technology to analyze vitreous body samples from both the FDM group and the control group. The goal of the proteomics analysis was to identify differences in protein expression within the vitreous body of FDM guinea pigs. Myopia was successfully induced in the FDM group after 4 weeks of modeling. A total of 6298 proteins were identified, among which 348 were differentially expressed proteins (DEPs), with 81 upregulated and 267 downregulated. These DEPs were subjected to in-depth bioinformatics analyses, including Gene Ontology, the Eukaryotic Orthologous Groups, and the Kyoto Encyclopedia of Genes and Genomes. These analyses revealed significant involvement in cellular processes, metabolic pathways, biological regulation, cytoskeletal organization, and cell movement. Our results indicate that calcium signaling plays a critical role in mediating eye changes associated with form deprivation, which may bear similarities to mechanisms observed in neurodegenerative diseases. A total of 348 DEPs related to the development and progression of myopia were identified. These changes involve key biological processes, including protein degradation, cell adhesion, and transport, especially alterations in calcium signaling pathways. Stromal interaction molecule 1 (STIM1) is an important biological marker of FDM, which was confirmed by Western blot, immunohistochemistry and ELISA. Our study found clear differences in the expression of proteins in the vitreous during the development of myopic guinea pigs, especially those related to calcium signaling pathway. Our study offers new insights into the pathogenesis of myopia, particularly changes related to protein metabolism pathways.

本研究旨在探讨豚鼠形觉剥夺性近视(FDM)玻璃体蛋白质组学的变化,从而揭示近视发生和发展的分子机制。通过用乳胶珠囊覆盖豚鼠的一只眼睛4周,成功建立了豚鼠近视模型。本研究利用四维数据独立采集蛋白质组学技术分析了FDM组和对照组的玻璃体样本。蛋白质组学分析的目的是确定 FDM 豚鼠玻璃体内蛋白质表达的差异。FDM 组在建模 4 周后成功诱导出近视。共鉴定出 6298 个蛋白质,其中 348 个为差异表达蛋白质(DEPs),81 个上调,267 个下调。对这些差异表达蛋白进行了深入的生物信息学分析,包括基因本体、真核同源组和京都基因和基因组百科全书。这些分析揭示了钙信号在细胞过程、代谢途径、生物调控、细胞骨架组织和细胞运动中的重要参与。我们的研究结果表明,钙信号在介导与形式剥夺相关的眼睛变化中起着关键作用,这可能与神经退行性疾病中观察到的机制相似。我们共发现了 348 个与近视的发生和发展相关的 DEPs。这些变化涉及关键的生物过程,包括蛋白质降解、细胞粘附和运输,尤其是钙信号通路的改变。基质相互作用分子 1(STIM1)是 FDM 的重要生物学标志物,这一点已通过 Western 印迹、免疫组织化学和 ELISA 得到证实。我们的研究发现,在近视豚鼠的发育过程中,玻璃体内蛋白质的表达存在明显差异,尤其是与钙信号通路相关的蛋白质。我们的研究为近视的发病机制,尤其是与蛋白质代谢途径相关的变化提供了新的见解。
{"title":"Proteomic insights into myopia development: Differential protein expression and the role of calcium signaling in form deprivation myopia in Guinea pigs","authors":"Rongbin Liang ,&nbsp;Tao Li ,&nbsp;Wenqing Shi ,&nbsp;Hui Gao ,&nbsp;Bei Ai ,&nbsp;Bing Li ,&nbsp;Xiaodong Zhou","doi":"10.1016/j.bmt.2024.06.001","DOIUrl":"https://doi.org/10.1016/j.bmt.2024.06.001","url":null,"abstract":"<div><p>This study aims to explore the changes in the vitreous proteomics of form deprivation myopia (FDM) in guinea pigs, in order to reveal the molecular mechanisms involved in the onset and development of myopia. The myopia model in guinea pigs was successfully established by covering one eye of the guinea pigs with a latex bead sac for 4 weeks. This study used 4D data-independent acquisition proteomics technology to analyze vitreous body samples from both the FDM group and the control group. The goal of the proteomics analysis was to identify differences in protein expression within the vitreous body of FDM guinea pigs. Myopia was successfully induced in the FDM group after 4 weeks of modeling. A total of 6298 proteins were identified, among which 348 were differentially expressed proteins (DEPs), with 81 upregulated and 267 downregulated. These DEPs were subjected to in-depth bioinformatics analyses, including Gene Ontology, the Eukaryotic Orthologous Groups, and the Kyoto Encyclopedia of Genes and Genomes. These analyses revealed significant involvement in cellular processes, metabolic pathways, biological regulation, cytoskeletal organization, and cell movement. Our results indicate that calcium signaling plays a critical role in mediating eye changes associated with form deprivation, which may bear similarities to mechanisms observed in neurodegenerative diseases. A total of 348 DEPs related to the development and progression of myopia were identified. These changes involve key biological processes, including protein degradation, cell adhesion, and transport, especially alterations in calcium signaling pathways. Stromal interaction molecule 1 (STIM1) is an important biological marker of FDM, which was confirmed by Western blot, immunohistochemistry and ELISA. Our study found clear differences in the expression of proteins in the vitreous during the development of myopic guinea pigs, especially those related to calcium signaling pathway. Our study offers new insights into the pathogenesis of myopia, particularly changes related to protein metabolism pathways.</p></div>","PeriodicalId":100180,"journal":{"name":"Biomedical Technology","volume":"7 ","pages":"Pages 15-24"},"PeriodicalIF":0.0,"publicationDate":"2024-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949723X24000126/pdfft?md5=c7b83f5cf95221d34931ea50c1ab4a18&pid=1-s2.0-S2949723X24000126-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141302971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biomaterials for cardiovascular diseases 治疗心血管疾病的生物材料
Pub Date : 2024-06-05 DOI: 10.1016/j.bmt.2024.05.001
Yongqi Huang , Ziqi Ding

Cardiovascular disease (CVD) remains a leading cause of mortality worldwide, claiming countless lives and posing a formidable health challenge. Extensive efforts have been dedicated to combating this disease, including the development of innovative biomaterials for blood vessel stents, drug delivery and imaging diagnosis. These advancements have substantially addressed issues such as patient rejection and blood contamination. In this review, we begin by outlining the prevalence and various forms of CVD. Subsequently, we delve into advanced biomaterials—including synthetic biomaterials, natural biomaterials, and hybrid biomaterials—and medical instruments used in the treatment or alleviation of CVD, discussing their advantages and limitations. Finally, we offer insights into future prospects and strategies for refining these technologies and instruments moving forward.

心血管疾病(CVD)仍然是全球死亡的主要原因,夺去了无数人的生命,对健康构成了严峻的挑战。人们为防治这种疾病付出了巨大努力,包括开发用于血管支架、药物输送和成像诊断的创新生物材料。这些进步极大地解决了患者排斥和血液污染等问题。在本综述中,我们首先概述了心血管疾病的发病率和各种形式。随后,我们深入探讨了用于治疗或缓解心血管疾病的先进生物材料(包括合成生物材料、天然生物材料和混合生物材料)和医疗器械,讨论了它们的优势和局限性。最后,我们将深入探讨完善这些技术和器械的未来前景和战略。
{"title":"Biomaterials for cardiovascular diseases","authors":"Yongqi Huang ,&nbsp;Ziqi Ding","doi":"10.1016/j.bmt.2024.05.001","DOIUrl":"https://doi.org/10.1016/j.bmt.2024.05.001","url":null,"abstract":"<div><p>Cardiovascular disease (CVD) remains a leading cause of mortality worldwide, claiming countless lives and posing a formidable health challenge. Extensive efforts have been dedicated to combating this disease, including the development of innovative biomaterials for blood vessel stents, drug delivery and imaging diagnosis. These advancements have substantially addressed issues such as patient rejection and blood contamination. In this review, we begin by outlining the prevalence and various forms of CVD. Subsequently, we delve into advanced biomaterials—including synthetic biomaterials, natural biomaterials, and hybrid biomaterials—and medical instruments used in the treatment or alleviation of CVD, discussing their advantages and limitations. Finally, we offer insights into future prospects and strategies for refining these technologies and instruments moving forward.</p></div>","PeriodicalId":100180,"journal":{"name":"Biomedical Technology","volume":"7 ","pages":"Pages 1-14"},"PeriodicalIF":0.0,"publicationDate":"2024-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949723X24000114/pdfft?md5=cb5784637ec851af912f15042bb6e167&pid=1-s2.0-S2949723X24000114-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141263997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum regarding missing Declaration of Competing Interest statements in previously published articles 关于以前发表的文章中缺少 "竞争利益声明 "的勘误
Pub Date : 2024-04-10 DOI: 10.1016/j.bmt.2024.04.001
{"title":"Erratum regarding missing Declaration of Competing Interest statements in previously published articles","authors":"","doi":"10.1016/j.bmt.2024.04.001","DOIUrl":"https://doi.org/10.1016/j.bmt.2024.04.001","url":null,"abstract":"","PeriodicalId":100180,"journal":{"name":"Biomedical Technology","volume":"6 ","pages":"Pages 91-92"},"PeriodicalIF":0.0,"publicationDate":"2024-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949723X24000023/pdfft?md5=8230957c0b6cf2e210228a9aa1877084&pid=1-s2.0-S2949723X24000023-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140543654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Biomedical Technology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1